Quality Systems Architecture · FDA Consulting

I help regulated companies operationalize CSA, stand up IEC 62304 SDLCs, and transition to QMSR.

12 years of FDA-regulated quality engineering across medical devices, pharma, and combination products. I've written the CAPAs, executed the protocols, survived the audits — and I write the software too.

Start a conversation LinkedIn
12+
Years FDA-regulated quality engineering
3
Regulatory domains — devices, pharma, combination products
21 CFR
Part 11 · Part 820 · Part 211 · ISO 13485 · IEC 62304 · EU MDR

FDA's CSA final guidance dropped September 2025. QMSR went effective February 2026. Every regulated company is in transition — and most are stuck.

Your CSV SOPs reference guidance that's been superseded. Your quality system was built for the old QSR. Your SaMD team is building without a compliant SDLC. These aren't future problems — auditors are asking about them now.

Services

CSA Program Buildout

Full transition from legacy CSV to FDA's Computer Software Assurance framework. Gap analysis, risk-based methodology, SOPs, templates, training, and a pilot assessment.

Sept 2025 final guidance is live. Your auditors will ask about CSA.

For: Quality & Regulatory leaders at device and pharma companies running legacy CSV programs

$15–25k
4–6 weeks

IEC 62304 SDLC Standup

Compliant software development lifecycle for SaMD/SiMD — safety classification, phase gates, requirements management, traceability, SOUP inventory, and risk integration per ISO 14971.

Agile-compatible per AAMI TIR45. Built to ship, not to slow you down.

For: SaMD/SiMD startups preparing for FDA submission

$20–30k
6–8 weeks

QMSR Gap Assessment

Full gap analysis against QMSR requirements (21 CFR 820 supplemental + ISO 13485:2016). Remediation plan, updated procedures, and inspection readiness assessment.

QMSR went effective February 2, 2026. The grace period is over.

For: Device companies navigating the QSR → QMSR transition

$10–18k
3–5 weeks

Fractional Head of Quality

Part-time quality leadership for early-stage companies. QMS ownership, design controls, CAPA management, supplier qualification, audit readiness, and regulatory interface.

Quality leadership without the $180k+ FTE commitment.

For: Seed to Series A SaMD/SiMD companies

$5–8k/mo
3-month minimum

Targeted engagements (Part 11 assessments, CAPA remediation, mock audits, training delivery) also available at $175–225/hr.

Not a typical quality consultant

Most quality consultants hand you a stack of Word templates and an invoice. I build the systems — procedures, tooling, and software. I write TypeScript and Python. I'm building CSA Workbench, an eQMS purpose-built for SaMD/SiMD, because every quality tool I've used was built by people who've never dispositioned a deviation.

Bench experience, not just theory

Auto-injectors at PCI Pharma Services for Eli Lilly. Combination products under 21 CFR 4. Class III medical devices. Sterile manufacturing. I've executed protocols at 2 AM, written 483 responses under deadline, and built quality systems from scratch. The consulting comes from the work, not a textbook.

No six-figure firm markup

Big consulting firms bill $300–500/hr and staff your project with junior associates who've never seen an FDA inspection. You get me — senior-level expertise, direct communication, no layers, no overhead. Project-based pricing aligned to outcomes, not billable hours.

Let's talk about what you're working through.

20-minute call. No pitch deck. Just a conversation about where you are and whether I can help.